📋 Tender Overview
Enhancing And Evolving Infrafrontier Disease Modelling Capacity To Enable Breakthrough Research
In Response To The Horizon-Infra-2023-Dev-01-03 Call, Infraplus Aims To Expand Infrafrontier~S Capacity For Human Disease Modelling, Refine Its Service Portfolio By Reducing Animal Usage And Developing Alternative Cellular Models, And Optimise The Use Of Resources. Infraplus Seeks To Achieve Several Objectives: Developing National Node Capacities And Expertise For Providing Innovative In Vivo, In Vitro And Preclinical Services, Developing Novel Model Systems And Services To Meet The Demands Of Existing And Novel User Communities, And Reducing Environmental Impact.
To Achieve These Objectives, Infraplus Will Focus On Launching Pilot Services, Refining New Technologies, Emphasising Alternate Cellular Models, Designing And Implementing Special Training Programmes And Optimising Resources For The Entire Consortium. The Project Includes A Defined Service Development Strategy Supported By A Strong It And Data Management Backbone And Is Built Upon The Needs Of The Scientific Community. Ultimately, Infraplus Will Enhance And Evolve Infrafrontier~S Capacity For Modelling Human Diseases And Enable Breakthrough Research By Providing Researchers Cutting-Edge Tools And Services To Respond To Global Biomedical Challenges.
Funded Under
Research Infrastructures
Total Cost
€ 4 999 863,75
Eu Contribution
€ 3 999 891,00
Coordinated By
Infrafrontier Gmbh
Germany
Start Date
1 June 2024
End Date
31 May 2027
Objective
In response to the HORIZON-INFRA-2023-DEV-01-03 call, INFRAPLUS aims to expand INFRAFRONTIER's capacity for human disease modelling, refine its service portfolio by reducing animal usage and developing alternative cellular models, and optimise the use of resources. INFRAPLUS seeks to achieve several objectives: Developing national node capacities and expertise for providing innovative in vivo, in vitro and preclinical services, developing novel model systems and services to meet the demands of existing and novel user communities, and reducing environmental impact.
To achieve these objectives, INFRAPLUS will focus on launching pilot services, refining new technologies, emphasising alternate cellular models, designing and implementing special training programmes and optimising resources for the entire consortium. The project includes a defined service development strategy supported by a strong IT and data management backbone and is built upon the needs of the scientific community. Ultimately, INFRAPLUS will enhance and evolve INFRAFRONTIER's capacity for modelling human diseases and enable breakthrough research by providing researchers cutting-edge tools and services to respond to global biomedical challenges.
